Passage Bio Stock (NASDAQ: PASG) stock price, news, charts, stock research, profile.
Open | $0.89 |
Close | - |
Volume / Avg. | 27.50K / 130.02K |
Day Range | 0.86 - 0.91 |
52 Wk Range | 0.58 - 1.79 |
Market Cap | $53.36M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 3.28% |
Days to Cover | 19.57 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Passage Bio (NASDAQ:PASG) through any online brokerage.
Other companies in Passage Bio’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), Intensity Therapeutics (NASDAQ:INTS), Barinthus Biotherapeutics (NASDAQ:BRNS) and CollPlant Biotechnologies (NASDAQ:CLGN).
There is no analysis for Passage Bio.
Passage Bio has a consensus price target of $8.17.
The stock price for Passage Bio (NASDAQ: PASG) is $0.8612 last updated July 19, 2024 at 5:41 PM EDT.
There are no upcoming dividends for Passage Bio.
Passage Bio’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Passage Bio.
Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.